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Abstract
A patient with rapidly fatal septic shock caused by group G /3-haemolytic streptococci as presenting symptom of 
acute myeloid leukaemia is presented. Although the association of septic shock due to Group G /3-haemolytic
I
streptococci and different kinds of malignancy is known, presentation of acute myeloid leukaemia in this form is 
rare.
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1. Introduction
Haemolytic streptococci represent a minority 
of micro-organisms that can cause septic shock. 
Although mortality due to infections by 
haemolytic streptococci is dependent on the 
Lancefield group, underlying disease is of great 
importance considering the outcome of the dis­
ease state [1], We present a patient in whom a 
rapidly fatal septic shock caused by Group G 
ß-haemolytic streptococci (HSGG) was the pre­
senting symptom of acute myeloid leukaemia.
* Corresponding author.
2. Case history
A 41-year-old male patient with no relevant 
clinical history complained a week before admis­
sion of pain in his right shoulder and both calves. 
A  trauma a few days before was thought to be 
responsible and diclofenac was prescribed. Four 
days after the beginning of his complaints he 
became feverish with chills, but no temperature 
was taken and no medical aid was sought. Two 
days after the chills had occurred he started 
vomiting, became progressively restless and dull, 
and was sent to the emergency department.
On admission we saw a restless man with whom  
no conversation was possible. His limbs were 
cyanotic, and haematomas on the right shoulder,
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upper arm and elbow and left thigh were seen. 
There were no petechiae and no signs o f skin 
abrasions, erysipelas or cellulitis could not be 
found and the skin between the toes was intact. 
Temperature was 37.2°C, blood pressure 1 0 0 / 60 
mmHg, pulse frequency 120 beats per minute. 
Pathological lymph nodes were not palpable and 
there was no sign of meningism. Investigation of
«
heart and lungs was normal, bowel sounds were 
normal and no signs of peritonitis could be found.
Laboratory values were as follows: Hb 5.6
mmol/1, Ht 0.27 1/1, WBC 25.7 X  109/1  (myelob­
lasts 2%, promyelocytes 12%, myelocytes 5%, 
metamyelocytes 20%, band forms 15%, segment
forms 7%, lymphocytes 22%, monocytes 17%), no
t
Auer rods. Urea 19.0 mmol/1, creatinine 174 
Atmol/1, LDH 1360 U / l ,  CPK 5226 U /l ,  platelets 
< 10 X 109/1 , fibrinogen 405 m g/1, FDP 95 mg/1, 
APTT > 272 s. Blood gas analysis: pH 7.31, p 0 2 
15.5 kPa, p C 0 2 1.6 kPa, base excess —16.6 
mmol/1, bicarbonate 6.0 mmol/1.
Urinanalysis by means of dipstick was positive 
for bacteria. Chest X-ray on admission was nor­
mal, X-ray of the right shoulder showed swollen 
soft tissue but no fractures. Ultrasonography of 
the abdomen revealed no abnormalities in the 
pancreatic region or kidneys.
Septic shock with diffuse intravascular coagu­
lation was diagnosed. After blood cultures were 
taken, intravenous antimicrobial treatment with 
piperacillin (4 g 3 times daily) and gentamicin 
(120 mg twice daily) was initiated.
Almost immediately after admission the pa­
tient became hypotensive, for which he was sub­
sequently treated with plasma expanders, packed 
red blood cells, fresh frozen plasma, thrombo­
cytes and vasopressors. Mechanical ventilation 
was necessary. A  chest X-ray taken 12 h after 
admission showed diffuse pulmonary oedema. On 
the morning after admission blood cultures grew 
ß-haemolytic streptococci of Lancefield Group G. 
Susceptibility testing by micro-broth dilution 
showed the organism to be susceptible to 
piperacillin (MIC < 0 .5  f i g / ml). Urine culture 
remained negative. Twenty hours after admission 
the patient died due to multiple organ failure. 
The post-mortem investigation revealed pe­
techiae, ecchymoses and haematomas in the skin,
conjunctivae, pleurae, lungs, heart, thyroid gland, 
kidneys, bowels and testes. There were signs of 
cardiomyopathy. All organ cultures remained 
negative. Analysis of bone marrow showed mas­
sive infiltration of leukaemic cells, compatible 
with acute myeloid leukaemiä. There was little 
leukaemic infiltration of liver and spleen.
3. Discussion
HSGG are normal inhabitants of the upper 
airways, gastrointestinal tract, female genital tract 
and skin, although a restriction is made by some 
authors to areas of moist skin such as toe webs
and perineum [2].
Infections caused by HSGG usually present as 
pharyngitis or superficial skin lesions, but more 
serious infections such as endocarditis, meningi­
tis, arthritis, osteomyelitis, sacro-iliitis, pyomyosi- 
tis and endophthalmitis have been described [3 -  
10]. Clinically, these often severe infections re­
semble those caused by Group A  and B strepto­
cocci.
HSGG are a rare cause of septic shock. Per­
centages less than 2 have been reported [1,11,12]. 
In our hospital, during the period 1988-1992 only 
15 (0.2%) out of 6982 positive blood cultures 
grew HSGG.
It has been reported that septic shock due to 
haemolytic streptococci can occur without any 
visible skin lesion, Several case studies have 
yielded conflicting results concerning the pres­
ence of skin lesions in patients with septic shock 
due to HSGG [12-16]. Predisposing factors such 
as alcoholism, diabetes, high age and neutropenia 
may be responsible for a facilitated entrance of 
bacteria. Our patient had a history of a recent 
trauma that might have caused skin lesions as 
possible portal of entry, but on physical examina­
tion no such lesions could be found.
Whereas infections caused by Group A  strep­
tococci can occur in otherwise healthy persons, 
infections or septic shock caused by HSGG have 
been reported to occur in the presence of under­
lying disease states such as malignancies [17]. 
Septic shock as presenting symptom of a previ­
ously undiagnosed malignancy, however, is rare.
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To the best of our knowledge there has only been 
one other report describing a patient with septic 
shock due to HSGG as presenting symptom of 
acute myeloid leukaemia [13]. This patient sur­
vived his septic shock and was subsequently 
treated for leukaemia. Our patient was a young 
and previously healthy man who was admitted in 
an almost moribund condition. While examining 
a peripheral blood slide shortly after admission, 
the diagnosis of acute leukaemia was considered, 
but no bone marrow study was performed be­
cause this would not have had therapeutic conse­
quences at that time. Histological confirmation of 
our suspicion of acute myeloid leukaemia was 
attained by post-mortem investigation.
Treating infections caused by HSGG is not 
different from treating infections caused by 
haemolytic streptococci of other Lancefield 
groups, although an exception has to be made for 
Group D streptococci or enterococci which are 
not susceptible to penicillin. Antibiotics as peni­
cillin G, vancomycin, first-generation cephalo­
sporins, erythromycin and piperacillin are active 
against HSGG.
In our hospital any patient suspected of having
b
septic shock is treated with a combination of a 
broad-spectrum ß -lactam antibiotic and an 
aminoglycoside. This combination gives rapid ad­
equate blood concentrations and a synergistic 
bactericidal effect has been observed in vitro [18].
We conclude that septic shock caused by 
HSGG as presenting symptom of acute myeloid 
leukaemia is a rare entity that adds to the previ­
ously described association of septic shock caused 
by these bacteria and different kinds of malignan­
cies. Any patient diagnosed of having septic shock 
caused by HSGG requires a full investigation to 
search for underlying malignancy.
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